Lilly’s Investigational Triple Agonist Retatrutide Reduces OSA Severity in Phase 3 Trial
Phase 3 TRIUMPH-1 trial data show retatrutide reduced the AHI by up to 36.1 events per hour alongside substantial weight loss.
Category: Sleep Treatments
Sleep Treatments
Latest
Sleep Treatments
Latest
Surprising Duration of Self-Maintained Positional Therapy Benefits Offers New OSA Strategy
Research presented at ATS 2026 reveals that positional therapy conditions patients to avoid back-sleeping, maintaining obstructive sleep apnea control for up to a year after device withdrawal.
Sleep Treatments
Latest
Will Orexin Drugs Raise the Bar for Clinical Diagnosis of Hypersomnolence?
As mechanism-based orexin agonists get close to market, sleep physicians may feel compelled to reduce ambiguity between narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia diagnoses.
CPAP & PAP Devices
Latest
CPAP Pillows Comparison Guide
This chart highlights key specifications and features among CPAP pillows, including adjustability, dimensions, materials, washability, and price.
Insomnia Devices
Latest
Peer-Reviewed Neuroimaging Data Supports Nexalin’s Technology for Chronic Insomnia
A newly published study reports significant clinical improvement and brain-network modulation in patients treated with the noninvasive neurostimulation device.
Therapy Devices
Latest
New TAP Sleep Care Collaboration Will Bring Its Oral Appliance Therapy to the Federal Healthcare System
The collaboration leverages MellingMedical’s federal contracting network to provide veterans and active-duty personnel with Airway Management's myTAP and myTAP PAP devices, aligning with 2025 VA/DoD guidelines.
Pharmaceuticals
Latest
Natrol Launches Ultra Sleep and Ultra Energy Supplements, Partners with Calm
The new dual-product system aims to support the 24-hour wellness cycle, accompanied by a strategic partnership with the Calm app to offer curated sleep content.
Surgeries & Procedures
Latest
Which Costs Less: GLP-1s or Bariatric Surgery?
A retrospective study explores how surgical and pharmacologic weight-loss strategies stack up in cost, effectiveness, and health outcomes.
Behavioral Sleep Medicine
Latest
New DARC-NESS Model Explains Why Nightmares Persist in Children
A mastery-based cognitive-behavioral model centers on "nightmare efficacy" to help clinicians create personalized treatment plans for youth.